TY  - BOOK
AU  - 	Ernst E. van der Wall
AU  -  P.K. Blanksma
AU  -  M.G. Niemeyer
AU  -  Willem Vaalburg
AU  - Harry J.G.M. Crijns
TI  - Advanced Imaging in Coronary Artery Disease: PET, SPECT, MRI, IVUS, EBCT
SN  - 9400708661
U1  - 616.12 WAL 
PY  - 2012///
CY  - New York 
PB  - Springer Science & Business Media
KW  -  
N1  - Contents:

Table of Contents

PET andPreclinical Coronary Artery Disease

Central neural correlates of silent myocardial ischemia

pathologic evidence

Plaque

Discussion

Raman spectra of coronary artery

Samplingdepth Raman spectroscopy combined with intravascular ultrasound

Preliminary report on thecentral neural correlates

Determination of prognosis after myocardial infarction

Pathophysiology of Acute or ShortTerm

Blood Flow and Metabolism

Imaging Techniques in Determining Myocardial

References

Introduction

Statistics

Conclusion

Cholesteroland thrombosis Effect ofcholesterol lowering therapy

Pathogenesis ofatherosclerosis

The atherosclerotic plaque

Atherosclerosis Atherosclerosis and imaging

Gated acquisition

Future developments in anatomy

Introduction

Myocardial Ischemia and Pain

Limitations of the study

Chapter15 FDG SPECT to Assess Myocardial Viability

Valueof Positron Emission Tomography

Quantitative LVEF measurement

Chapter 18Magnetic Resonance Imaging of Cardiac Function

Conclusion

Cardiac βadrenoceptors


Chapter 20Surgical Treatment of Heart Failure

Volume Reduction of the Left Ventricle Batista Procedure

N2  - In Advanced Imaging in Coronary Artery Disease, the role of several imaging techniques in diagnosing atherosclerosis, assessment of myocardial ischemia, myocardial viability, and heart failure are broadly discussed. The issues derived from cardiac PET are presented in relation to the conventional techniques, such as echocardiography, SPECT and MRI. In addition, newer imaging techniques such as intracoronary ultrasound, electron beam computed tomography, and Raman spectroscopy are given wide attention. The effects of drug treatment, such as anti-ischemic and lipid-lowering drugs, are also evaluated.
This book will assist clinical cardiologists, nuclear medicine physicians, fellows in cardiology and nuclear medicine, radiochemists, basic research fellows, and technicians, in understanding the new advances in clinical cardiac PET
ER  -